Aterian (NASDAQ:ATER) Shares Cross Above 200-Day Moving Average – What’s Next?

Aterian, Inc. (NASDAQ:ATER – Get Free Report) shares passed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $0.77 and traded as high as $0.8232. Aterian shares last traded at $0.8050, with a volume of 114,176 shares trading hands.

Wall Street Analysts Forecast Growth

ATER has been the subject of a number of research analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Aterian in a report on Friday, August 14th. Wall Street Zen cut Aterian from a “hold” rating to a “sell” rating in a report on Saturday, July 25th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Read Our Latest Report on Aterian

Aterian Trading Down 1.9%

The stock’s 50-day moving average is $0.64 and its 200-day moving average is $0.77. The stock has a market cap of $7.99 million, a price-to-earnings ratio of -0.40 and a beta of 1.37.

Aterian (NASDAQ:ATER – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.43) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.26). Aterian had a negative net margin of 49.30% and a negative return on equity of 92.04%. The business had revenue of $0.01 million for the quarter, compared to analyst estimates of $20.30 million.

About Aterian

(Get Free Report)

Aterian, Inc (NASDAQ: ATER) is a technology-enabled consumer products company that develops, acquires and sells products through online retail channels. Its portfolio has included household, kitchen, health and wellness, beauty, outdoor and other consumer-focused products marketed under a range of brands.

The company uses data analytics, software and automation to identify product opportunities, manage sourcing and manufacturing, optimize marketing, and support sales and inventory decisions.

See Also

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.